Pseudotumor following total hip arthroplasty: experience of a tertiary referral center and proposal of the new "PCS" classification system

全髋关节置换术后假瘤:三级转诊中心的经验及新的“PCS”分类系统建议

阅读:1

Abstract

INTRODUCTION: This study summarizes outcomes in treating pseudotumors of the hip at a tertiary referral center and introduces a classification system to aid treatment decisions and enhance communication among providers. MATERIALS AND METHODS: We collected data from 39 patients who underwent surgery for hip pseudotumor, analyzing implant failures based on patient history, revision reasons, bearing surface type, mass location and size, bone loss, revision type, and whether it was single- or two-stage. We introduce the PCS classification: 'P' for Pseudotumor (with 's' for symptomatic, 'e/I' for intra/extrapelvic location, and 'm' for high Chromium/Cobalt levels), 'C' for implant status, and 'S' for bone loss extent. In 37 patients, we evaluated Cohen's kappa coefficient to evaluate interobserver reliability. RESULTS: Twenty (51.2%) patients were female, with a mean age of 71 years (range 36-89; σ 12.11); the mean follow-up duration was 54.43 months (range 12.2-128.3). The average size of the pseudotumor was 13.10 cm (range 3.3-37.2; σ 7.11) with 61.5% exhibiting extra-pelvic localization only. Bearing surfaces were MoM in 27 patients (69.2%). Single-stage revision surgery was performed in 87.1% of patients. There were 7 (17.9%) implant failures. No significant differences in failure rates were observed based on considered parameters. The agreement following Cohen's coefficient for the combined PCS classification was k = 0.43. Moderate to almost perfect agreement was obtained for parameter P and S, with k = 0.48 for parameter C. CONCLUSION: No correlation was found between failures and analyzed characteristics. Our classification assesses clinical scenarios and stratifies surgical complexity for indication purposes. While interobserver agreement varies with parameter C, it is consistent with parameters P and S.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。